Relapse rates after withdrawal versus maintaining biologic therapy in IBD patients with prolonged remission

Biologic treatment withdrawal in inflammatory bowel disease patients with prolonged remission may lead to benefits but also increases the risk of getting a relapse. The risk of relapse after biologic withdrawal according to the Dutch STOP-criteria is still unknown. The aim of this study was to compa...

Descripción completa

Detalles Bibliográficos
Autores principales: Stoker, Annemay M. H., Logghe, Leslie, van der Ende-van Loon, Mirjam C. M., Schoon, Erik J., Schreuder, Ramon-Michel, Stronkhorst, Arnold, Gilissen, Lennard P. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9838337/
https://www.ncbi.nlm.nih.gov/pubmed/36633694
http://dx.doi.org/10.1007/s10238-023-00994-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9838337/
https://www.ncbi.nlm.nih.gov/pubmed/36633694
http://dx.doi.org/10.1007/s10238-023-00994-6

Ejemplares similares